After easing into the EV market with the awkwardly named bZ4X, now rebranded simply as bZ, Toyota seems determined to make an ...

Mature overall survival results of the INAVO120 trial were presented in a press conference for the American Society of ...

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

Coupe-crossover returns to the US market as an EV with standard AWD and more than twice the power of the original C-HR ...

The amount of CDK4/6-targeting treatment options available for patients with HR-positive breast cancer allows providers to ...

Toyota is expanding its electric car line-up with the introduction of the new bZ4X Touring. The new model is a more practical ...

On May 15, 2025, the latest announcement released by the National Medical Products Administration attracted widespread attention in the oncology community and the pharmaceutical market. Bireociclib ...

The last C-HR wasn't a stellar hit in the US, but this new one promises near-sports car performance in a practical SUV ...

The Toyota C-HR is making a return to the United States several years after the nameplate was discontinued at the end of 2022 ...

It’s official. Toyota is finally launching a new EV in the US. The C-HR will return in what’s expected to be an affordable ...

The C-HR grows up, and now has performance to match its looks.Toyota on Wednesday announced the return of one of its more ...